CRCM LP

CRCM LP, managed by Chun Ding, reported 14 positions worth $152.16M in its 2026 Q2 13F filing: 7 new and 1 closed.

Estimated return

Since 2025 Q2 the disclosed positions returned an estimated +28.8% against +34.4% for the S&P 500. Price-only return of the fund's top 100 US longs at each quarter start, vs the S&P 500 over the same windows. Not the fund's actual return (no trades, fees, shorts, derivatives, cash).

QuarterFundS&P 500
2025 Q2+57.4%+11.4%
2025 Q3+14.5%+7.6%
2025 Q4+4.2%+3.1%
2026 Q1-16.0%-5.8%
2026 Q2-18.4%+15.5%

Top holdings, 2026 Q2

TickerCompanyValuePortfolio %Change
IAUISHARES GOLD TRUST ETF$99.21M65.20%+5.1%
IBITISHARES BITCOIN TRUST ETF$10.11M6.60%NEW
RNAATRIUM THERAPEUTICS INC$8.63M5.70%NEW
AIFCAI FINANCIAL CORP$7.43M4.90%+0.7%
PLBYPLAYBOY INC$7.02M4.60%+32.5%
BTGOBITGO HOLDINGS INC-CL A$6.80M4.50%NEW
SGOVISHARES 0-3 MONTH TREASURY B$4.76M3.10%NEW
VZLAVIZSLA SILVER CORP$2.80M1.80%NEW
BNRBURNING ROCK BIOTECH LTD-ADR$1.77M1.20%-24.8%
PCAPPROCAP ACQUISITION CORP - A$1.65M1.10%+5.4%
PCSCPERCEPTIVE CAPITAL SOLUTIONS$1.06M0.70%-16.3%
TRAXFIRST TRACKS BIOTHERAPEUTICS$711.04K0.47%NEW
USBCUSBC INC.$173.82K0.11%NO CHANGE
PCAPWPROCAP ACQUISITION CORP$32.88K0.02%NEW

All funds · Hedge Fund Tracker

Source: SEC EDGAR 13F filings, reported as of quarter end and filed up to 45 days later. Not investment advice.